Location: Home
  • search
  • go
  • Relate News
  • 4/29/2025XellSmart Receives NMPA Approval for Landmark Trial of "On-Demand" iP...
  • 4/29/2025JW and Juno Forge sLVV Licensing Agreement to Advance Cell Therapy Man...
  • 4/29/2025Frontera's Gene Therapy FT-017 Achieves Dual Regulatory Clearance in U...
  • 4/29/2025China's Hospital Drug Market Shows Slight Growth in 2024, Driven by On...
  • 4/29/2025China NMPA Suspends Digoxin API Imports from VITAL LABS
  • 4/29/2025Hengrui Secures Approval for Hong Kong IPO
  • 4/29/2025InnoCare's Orelabrutinib Receives NMPA Approval as First-Line Therapy ...
  • 4/29/2025Innovent Announces NMPA Approval of Limertinib
  • 4/29/2025AmCham China Reports Chinese Tariff Exemptions for Some Pharma Firms A...
  • 4/29/2025Europe Emerges as Key Partner for China Pharma Deals Amid US Market Sh...
  • 4/29/2025ConjugateBio Secures Exclusive Option for Escugen's EZWi-Fit® Platfor...
  • 4/29/2025BeiGene's Novel Cancer Drug Sonrotoclax Seeks Approval in China
  • 4/29/202553 Original Research Drugs Approved in China in Early 2025
  • 4/29/2025State Council Approves Draft Medical Security Law, Strengthening Fund ...
  • 4/29/2025China Orders Drugmakers, Hospitals to Study US Import Replacements
  • 4/29/2025AstraZeneca's China Business Recovers in Q1 2025 Amid Easing Regulator...
  • 4/29/2025High Return Rate: Are Chinese Innovative Drugs Facing a "Breakup" Cris...
  • 4/26/2025China Aims for Significant Pharma Industry Digital Transformation by 2...
  • 4/26/2025Recent Executive Moves
  • 4/25/2025JIBP Aims for Hong Kong IPO amid Biopharma Market Revival
  • 4/25/2025AstraZeneca China Announces Major Reorganization to Bolster Biopharma ...
  • 4/25/2025China's Fast-Track Drug Approvals Accelerating Access to Novel Therapi...
  • 4/25/2025NMPA Approves Expanded Use of JNJ's Rybrevant for Advanced EGFR-Mutate...
  • 4/25/2025Akeso's Penpulimab Secures FDA Approval for Nasopharyngeal Carcinoma
  • 4/25/2025Akeso's Ivonescimab Gains Second Approval in China
  • 4/25/2025China Greenlights Recordati's Long-Acting Pasireotide for Uncontrolled...
  • 4/25/2025China's Innovative Drug Licensing Deals Soar, Big Pharma Leads the Buy...
  • 4/25/2025Cell Therapy to AI: How J&J Has Been Sourcing the Transformational Sci...
  • 4/25/2025MNC Pharma's Q1/2025 China Performance: Divergent Fortunes Amid Pricin...
  • 4/24/2025US Capital Crunch Pushes China Biotechs to Roundabout Financings (Phar...
  • Page:38/800 Total number of articles:23988: [First][<<] [36] [37] [38] [39] [40] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group